SCHEMBL21946981

SCHEMBL21946981

CC[C@@H]1COC[C@]1(C)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30782086 0.82 — —
SCHEMBL18932496 0.73 — —
SCHEMBL24754418 0.71 — —
SCHEMBL25467342 0.70 — —
SCHEMBL18098474 0.69 — —
SCHEMBL12333679 0.69 — —
SCHEMBL24477927 0.69 — —
SCHEMBL20723392 0.69 — —
SCHEMBL29631601 0.69 — —
SCHEMBL4269786 0.69 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200131201-A1 TYK2 INHIBITORS AND USES THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2020-04-30 — — US disclosed
WO-2020081508-A1 TYK2 INHIBITORS AND USES THEREOF NIMBUS LAKSHMI, INC. (US) 2020-04-23 — — WO disclosed
Send feedback